Shareholders That Lost Money on Neumora Therapeutics, Inc. (NMRA) Should Contact Levi & Korsinsky about Pending Class Action - NMRA
Portfolio Pulse from
Law firm Levi & Korsinsky has initiated a class action lawsuit against Neumora Therapeutics (NMRA) alleging the company made false statements and concealed critical information about its Phase Two clinical trials for Navacaprant, its therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit claims the company manipulated trial inclusion criteria and statistical analysis to show potential efficacy.
March 21, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Class action lawsuit alleges manipulation of clinical trial data, which could negatively impact investor confidence and stock performance
The lawsuit directly targets Neumora Therapeutics, alleging serious misconduct in clinical trial reporting. Such legal challenges typically create investor uncertainty, potentially leading to stock price decline.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100